Body burden of cancer in relationship to therapeutic outcome: consideration of preclinical evidence.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000601:surgery / Q000628:therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000633:toxicity; D002470:Cell Survival / Q000187:drug effects; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D007939:Leukemia L1210 / Q000188:drug therapy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000601:surgery / Q000628:therapy; D008545:Melanoma / Q000188:drug therapy / Q000601:surgery / Q000628:therapy; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000473:pathology*; D014411:Neoplastic Stem Cells / Q000187:drug effects
D000970:Antineoplastic Agents; D003520:Cyclophosphamide